Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Andre

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2008
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacyM Zoubir, M C Mathieu, C Mazouni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancerF Andre, R Conforti, C B Moeder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2017
Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancerR Condorelli, L Spring, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2006
Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancerF Andre, N Cabioglu, H Assi, et al.
Ecology and Evolution|April 22, 2017
How repeatable is the Environmental Impact Classification of Alien Taxa (EICAT)? Comparing independent global impact assessments of amphibiansSabrina Kumschick, G John Measey, Giovanni Vimercati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcomeJ-P Spano, F Andre, L Morat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancerF Meslin, R Conforti, C Mazouni, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2019
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancerM Campone, T Bachelot, F Penault-Llorca, et al.
Herz|March 4, 2022
[Morphological and functional diagnostics of coronary artery disease by computed tomography]S Baumann, D Overhoff, C Tesche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancerF Andre, R Nahta, R Conforti, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 26, 2008
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacyM Zoubir, M C Mathieu, C Mazouni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancerF Andre, R Conforti, C B Moeder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2017
Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancerR Condorelli, L Spring, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2006
Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancerF Andre, N Cabioglu, H Assi, et al.
Ecology and Evolution|April 22, 2017
How repeatable is the Environmental Impact Classification of Alien Taxa (EICAT)? Comparing independent global impact assessments of amphibiansSabrina Kumschick, G John Measey, Giovanni Vimercati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcomeJ-P Spano, F Andre, L Morat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancerF Meslin, R Conforti, C Mazouni, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2019
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancerM Campone, T Bachelot, F Penault-Llorca, et al.
Herz|March 4, 2022
[Morphological and functional diagnostics of coronary artery disease by computed tomography]S Baumann, D Overhoff, C Tesche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancerF Andre, R Nahta, R Conforti, et al.
Pageof 12